Abstract
A series of new furazan (1,2,5-oxadiazole) derivatives based on structural overlap with combretastatin have been synthesized. Targeted molecules were evaluated using the sea urchin embryo assay; several agents demonstrated 1–4μmol dm–3 antiproliferative activity in this in vivo model.
References
1.
Jordan M.A., Wilson L.
Nature Reviews Cancer,
2004
2.
Kiselyov A., Balakin K.V., Tkachenko S.E., Savchuk N., Ivachtchenko A.V.
Anti-Cancer Agents in Medicinal Chemistry,
2007
3.
L. Wordenmam and T. J. Mitchison, in Microtubules, eds. J. S. Hyams and C. W. Lloyd, Wiley-Liss, New York, 1994, p. 287.
4.
10.1016/j.mencom.2010.05.002_bib4
Rowinsky
J. Natl. Cancer Inst.,
1993
5.
10.1016/j.mencom.2010.05.002_bib5
Pitot
Clin. Cancer Res.,
1999
6.
10.1016/j.mencom.2010.05.002_bib6
Cole
Cancer Res.,
1994
7.
10.1016/j.mencom.2010.05.002_bib7
Lorico
Cancer Res.,
1996
8.
Kavallaris M., Kuo D.Y., Burkhart C.A., Regl D.L., Norris M.D., Haber M., Horwitz S.B.
Journal of Clinical Investigation,
1997
9.
Giannakakou P., Sackett D.L., Kang Y., Zhan Z., Buters J.T., Fojo T., Poruchynsky M.S.
Journal of Biological Chemistry,
1997
10.
Nogales E., Whittaker M., Milligan R.A., Downing K.H.
Cell,
1999
11.
10.1016/j.mencom.2010.05.002_bib11
Brown
Top. Heterocycl. Chem.,
2006
12.
Tron G.C., Pagliai F., Del Grosso E., Genazzani A.A., Sorba G.
Journal of Medicinal Chemistry,
2005
13.
Ouyang X., Piatnitski E.L., Pattaropong V., Chen X., He H., Kiselyov A.S., Velankar A., Kawakami J., Labelle M., Smith L., Lohman J., Lee S.P., Malikzay A., Fleming J., Gerlak J., et. al.
Bioorganic and Medicinal Chemistry Letters,
2006
14.
X. Ouyang, A. Kiselyov, X. Chen, H.-Y. J. He, J. Kawakami, V. Pattaropong, E. Piatnitski, M. C. Tuma and J. Kincaid, US Patent WO 2005/004818 A2, 2005.
15.
Ouyang X., Chen X., Piatnitski E.L., Kiselyov A.S., He H., Mao Y., Pattaropong V., Yu Y., Kim K.H., Kincaid J., Smith L., Wong W.C., Lee S.P., Milligan D.L., Malikzay A., et. al.
Bioorganic and Medicinal Chemistry Letters,
2005
16.
Semenova M.N., Kiselyov A., Semenov V.V.
BioTechniques,
2008
17.
Semenova M.N., Kiselyov A.S., Titov I.Y., Raihstat M.M., Molodtsov M., Grishchuk E., Spiridonov I., Semenov V.V.
Chemical Biology and Drug Design,
2007
18.
10.1016/j.mencom.2010.05.002_bib18
Andrianov
Khim. Geterotsikl. Soedin.,
1994
19.
10.1016/j.mencom.2010.05.002_bib19
Yarovenko
Izv. Akad. Nauk, Ser. Khim.,
1994
20.
10.1016/j.mencom.2010.05.002_bib20
Andrianov
Khim. Geterotsikl. Soedin.,
1988
21.
10.1016/j.mencom.2010.05.002_bib21
Andrianov
Khim. Geterotsikl. Soedin.,
1990
22.
10.1016/j.mencom.2010.05.002_bib22
Andrianov
Khim. Geterotsikl. Soedin.,
1991
23.
10.1016/j.mencom.2010.05.002_bib23
Andrianov
Khim. Geterotsikl. Soedin.,
1994
24.
Ichikawa T., Kato T., Takenishi T.
Journal of Heterocyclic Chemistry,
1965
25.
10.1016/j.mencom.2010.05.002_bib25
Andrianov
Khim. Geterotsikl. Soedin.,
1988
26.
Beaudegnies R., Wendeborn S.
Heterocycles,
2003
27.
10.1016/j.mencom.2010.05.002_bib27
Sheremetev
Izv. Akad. Nauk, Ser. Khim.,
2004
28.
Novikova T.S., Mel’nikova T.M., Kharitonova O.V., Kulagina V.O., Aleksandrova N.S., Sheremetev A.B., Pivina T.S., Khmel’nitskii L.I., Novikov S.S.
Mendeleev Communications,
1994
29.
10.1016/j.mencom.2010.05.002_bib29
Sheremetev
Zh. Org. Khim.,
1999